NCT06563635

Frequency of Tuberculosis in Psoriasis Patients

Frequency of Tuberculosis in Psoriasis Patients Using Anti-TNF Therapy During 15 Years of Follow-up.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 719 (actual)
• Sponsor: Bezmialem Vakif University · Academic / Other
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: —

Summary

Aim of this study is evaluation of patients receiving TNF inhibitor therapy in terms of tuberculosis at the end of 15 years in a single center.

Detailed description

Aim of this study is evaluation of patients receiving TNF inhibitor therapy in terms of tuberculosis at the end of 15 years in a single center. TNF inhibitor therapy may increase the risk for tuberculosis infection. According to medical data in our hospital in last 15 years, tuberculosis rate of psoriasis patients receiving etanercept, adalimumab and infliximab will be compared.

Conditions

• Psoriasis Vulgaris
• Tuberculosis

Timeline

• Start date: 2023-05-01
• Primary completion: 2023-07-31
• Completion: 2023-07-31
• First posted: 2024-08-21
• Last updated: 2024-08-21

Locations

1 site across 1 country: Turkey (Türkiye)